 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
7 L( }# p' o: h/ m+ ?4 ~0 |
' s2 \; x3 B$ |& ? x! ~. p* H/ P/ tEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.; ^2 x" g. Z, [# n
0 R! n4 @- |2 @( U7 V! i+ TBY THE EDMONTON JOURNAL FEBRUARY 16, 2007& I. ~3 w& C2 I& \2 C7 X
. e5 Y/ _& B% S, e0 V8 B% ~5 S1 u
B6 G0 Q1 Q3 o( e) o1 N& X+ QEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
2 p8 F4 r. c! f- D- y* a2 H! l6 i
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."6 k) H, h1 `' }5 T
$ F( Y+ R5 x! X( K6 eThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product. B1 R7 X& u: a+ ?
5 ^# H: |4 r' V8 i E
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
7 ?) n# b" u" B9 C$ j% } n. l1 i9 ^, _% G# R8 e# K' w2 R! H
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
; k- v) t0 u: ]- n- J
6 ^8 N5 z# R2 A* @. f: I"As a scientist, it's one of the highlights of my CAREER," Shan said., N5 {6 p- i8 t+ q1 J! n4 x0 r1 E% L9 O
" o: w# d0 r5 f& a' i6 ~. c9 J
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."6 j/ p- y) ?* p/ \1 g, v
" |- }( s5 o4 w" PIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.. j* S" B; W9 o3 R n( j
7 V9 e J+ n7 M* Y$ p; k0 s' X- aGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth./ b' n& q$ ]5 B
4 Q0 u1 O4 t9 m2 Z3 KThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.3 Z7 n4 n ?0 e' T0 ]* A
$ j+ R2 S/ b) @) p7 L2 e$ p% Z) T6 O1 F0 J+ l1 Q7 A1 |
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
/ q5 C5 o2 s, `$ y( i* O( S7 u
发表于 2015-2-28 19:45
